BIOLASE, Inc. (NASDAQ: BIOL) saw a relatively subdued trading day on Thursday, with its shares ticking up by a marginal 0.60% from $0.1491 to $0.1500.
The dental lasers developer, Biolase Inc. (BIOL) witnessed a wild day as investors rushed toward the stock like crazy on April 28, 2022. Intraday trading,
The dental device firm is bullish and looks solid for long-term growth. The medical device firm, BIOLASE Inc. (BIOL) had a good last twelve months–soaring
On January 20, American stock markets closed at new all-time highs. The S&P 500 index rose 1.39% to 3852 points, the NASDAQ rose 1.97%, the
Bionano Genomics Inc. (BNGO) stock soared 55.84% to $4.8 in the pre-market trading. The company recently granted 180-day extension by Nasdaq to regain compliance with
Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-market trading after reporting that Praxis Genomics, LLC received accreditation from the College of
Greenpro Capital Corp. (GRNQ), a Conglomerates company, dropped about -5.88% at $1.76 in pre-market trading Tuesday after announcing Bitcoin fund. ATIF Holdings Limited (ATIF) stock
Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after reporting the appointment of a vaccine scientific advisory board comprised of leading
Ocugen Inc. (OCGN) stock soared 77.6% to $1.43 in the pre-market trading after signing a binding letter of intent (LOI) with Bharat Biotech to develop
New medical innovations are emerging day by day and are playing a major role in the health care sector. Much of the credit for these
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.